COVID-19 Response

CHRISTUS Health is fully equipped to provide safe, quality care to our communities. Learn More

COVID-19 Research

To help combat the wildly spreading COVID-19 pandemic and make meaningful contributions towards the advancement of science and medicine, the CHRISTUS Institute for Innovation and Advanced Clinical Care (CIIACC) remains strategically focused on bringing cutting-edge and innovative clinical research participation opportunities to our diverse patients. During the ongoing public health crisis, CIIACC is committed to be at the forefront for identifying solutions to the evolving science around COVID-19 disease. Our aim is to closely work with government, industry, and academia to attract and offer the safest, scientifically meritorious, and most relevant clinical research participation opportunities to the many diverse communities we serve across the States of Texas, Louisiana, and New Mexico in USA, and internationally across Mexico, Colombia and Chile. 

COVID-19 Research Sites at CHRISTUS Health

 

Texas, USA: San Antonio, San Marcos, New Braunfels, Corpus Christi, Beeville, Alice, Kingsville, Beaumont, Jasper, Tyler, Sulphur Springs, Jacksonville, Winnsboro, Longview, Marshall, Texarkana, Atlanta

Louisiana, USA: Shreveport-Bossier, Alexandria, Coushatta, Lake Charles

New Mexico, USA: Santa Fe

Mexico: Monterrey, Nuevo Leon

Chile: Santiago, Chile

 

Select Ongoing COVID-19 Clinical Research at CHRISTUS Health

 
  • Screening Research
  • Treatment Research (Innovative Therapies)
  • Treatment Research (Drugs)
  • Surveillance Research

CHRISTUS COVID-19 Research in the News

image of Coronavirus Disease 2019 (COVID-19)

Learn More